Rights and permissions
About this article
Cite this article
Gemcitabine regimen cost effective in cervical cancer. Pharmacoecon. Outcomes News 662, 7 (2012). https://doi.org/10.2165/00151234-201206620-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206620-00018